Skip to main content
OpenTrials

Clinical trial condition

Microscopic Polyangiitis

Explore clinical trials studying Microscopic Polyangiitis. Study availability and eligibility vary by location and protocol.

50 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Microscopic Polyangiitis trial results

Completed

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

NCT00315393

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

NCT02115997

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • Yashoda Hospital Hyderabad, Andhra Pradesh, India
  • MULJIBHAI PATEL UROLOGICAL HOSPITAL; Nephrology Gujarat, India
  • Medanta-The Medicity Gurgaon, Haryana, India
  • Fortis Memorial Research Instititute Gurgaon, Haryana, India
View Trial Details
Completed

Rituximab Vasculitis Maintenance Study

NCT01697267

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Hospital for Special Surgery New York, United States
View all 38 locations
View Trial Details
Completed

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

NCT00987389

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 98 locations
View Trial Details
Completed

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Belimumab in Remission of VASculitis

NCT01663623

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +17 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Covina, California, United States
View all 89 locations
View Trial Details
Completed

The ANCA Vasculitis Questionnaire (AAV-PRO©)

NCT02507024

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +28 more
Locations
  • University of South Florida Tampa, Florida, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions